Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
AdventHealth Orlando, Orlando, Florida Washington University School of Medicine, St Louis, Missouri Ohio State University Comprehensive Cancer Center, Columbus, Ohio The University of Texas MD Anderson Cancer Center, Houston, Texas United Kingdom
University College London NHS FT, London The Royal Marsden NHS Foundation Trust, Sutton